Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
AUTOR(ES)
van der Veldt, A A M
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2768095Documentos Relacionados
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience
- Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
- Reply: Do we need biopsies of metastases for colorectal cancer patients?
- Phase II study of sunitinib in men with advanced prostate cancer